CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- Open-market buys, last 90 days
- $226,500
- in 1 filing
- Open-market sales, last 90 days
- $4,661,919
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,435,419. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | Kling Douglas F Chief Operating Officer | Option exercise 10b5-1 | +90,782 | 134,782 | ||
| 2025-02-18 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −90,782 | 44,000 | ||
| 2025-02-18 | Kling Douglas F Chief Operating Officer | Option exercise · Option (right to buy) 10b5-1 | −90,782 | 135,363 | ||
| 2025-01-30 | Kling Douglas F Chief Operating Officer | Option exercise 10b5-1 | +13,578 | 57,578 | ||
| 2025-01-30 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −4,664 | 52,914 | ||
| 2025-01-30 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −8,914 | 44,000 | ||
| 2025-01-30 | Kling Douglas F Chief Operating Officer | Option exercise · Option (right to buy) 10b5-1 | −13,578 | 226,145 | ||
| 2025-01-29 | Kling Douglas F Chief Operating Officer | Option exercise 10b5-1 | +56,863 | 100,863 | ||
| 2025-01-29 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −56,863 | 44,000 | ||
| 2025-01-29 | Kling Douglas F Chief Operating Officer | Option exercise · Option (right to buy) 10b5-1 | −56,863 | 239,723 | ||
| 2025-01-28 | Somaiya Mayur Ian Chief Financial Officer | Option exercise 10b5-1 | +14,900 | $9.26 | $138K | 52,900 |
| 2025-01-28 | Somaiya Mayur Ian Chief Financial Officer | Sale 10b5-1 | −11,495 | 41,405 | ||
| 2025-01-28 | Somaiya Mayur Ian Chief Financial Officer | Sale 10b5-1 | −3,405 | 38,000 | ||
| 2025-01-28 | Somaiya Mayur Ian Chief Financial Officer | Option exercise · Option (Right to Buy) 10b5-1 | −14,900 | 762,814 | ||
| 2025-01-28 | Kling Douglas F Chief Operating Officer | Option exercise 10b5-1 | +25,385 | 69,385 | ||
| 2025-01-28 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −20,237 | 49,148 | ||
| 2025-01-28 | Kling Douglas F Chief Operating Officer | Sale 10b5-1 | −5,148 | 44,000 | ||
| 2025-01-28 | Kling Douglas F Chief Operating Officer | Option exercise · Option (right to buy) 10b5-1 | −25,385 | 296,586 | ||
| 2025-01-27 | Somaiya Mayur Ian Chief Financial Officer | Option exercise 10b5-1 | +46,983 | $9.26 | $435K | 84,983 |
| 2025-01-27 | Somaiya Mayur Ian Chief Financial Officer | Sale 10b5-1 | −33,679 | 51,304 |
Page 11 of 15 · 300 trades